126 related articles for article (PubMed ID: 37768560)
1. A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023.
Takashita E; Fujisaki S; Morita H; Nagata S; Miura H; Matsuura Y; Yamamoto S; Chiba S; Inoue Y; Minami I; Yoshikawa S; Yamazaki S; Kishida N; Nakamura K; Shirakura M; Watanabe S; Hasegawa H
Euro Surveill; 2023 Sep; 28(39):. PubMed ID: 37768560
[TBL] [Abstract][Full Text] [Related]
2. Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019.
Takashita E; Kawakami C; Ogawa R; Morita H; Fujisaki S; Shirakura M; Miura H; Nakamura K; Kishida N; Kuwahara T; Ota A; Togashi H; Saito A; Mitamura K; Abe T; Ichikawa M; Yamazaki M; Watanabe S; Odagiri T
Euro Surveill; 2019 Mar; 24(12):. PubMed ID: 30914078
[TBL] [Abstract][Full Text] [Related]
3. Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019.
Takashita E; Ichikawa M; Morita H; Ogawa R; Fujisaki S; Shirakura M; Miura H; Nakamura K; Kishida N; Kuwahara T; Sugawara H; Sato A; Akimoto M; Mitamura K; Abe T; Yamazaki M; Watanabe S; Hasegawa H; Odagiri T
Emerg Infect Dis; 2019 Nov; 25(11):2108-2111. PubMed ID: 31436527
[TBL] [Abstract][Full Text] [Related]
4. Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018.
Takashita E; Kawakami C; Morita H; Ogawa R; Fujisaki S; Shirakura M; Miura H; Nakamura K; Kishida N; Kuwahara T; Mitamura K; Abe T; Ichikawa M; Yamazaki M; Watanabe S; Odagiri T;
Euro Surveill; 2019 Jan; 24(3):. PubMed ID: 30670142
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
[TBL] [Abstract][Full Text] [Related]
6. Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
Uehara T; Hayden FG; Kawaguchi K; Omoto S; Hurt AC; De Jong MD; Hirotsu N; Sugaya N; Lee N; Baba K; Shishido T; Tsuchiya K; Portsmouth S; Kida H
J Infect Dis; 2020 Jan; 221(3):346-355. PubMed ID: 31309975
[TBL] [Abstract][Full Text] [Related]
7. Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model.
Koszalka P; George A; Dhanasekaran V; Hurt AC; Subbarao K
mBio; 2022 Aug; 13(4):e0105622. PubMed ID: 35938724
[TBL] [Abstract][Full Text] [Related]
8. Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons.
Gubareva LV; Mishin VP; Patel MC; Chesnokov A; Nguyen HT; De La Cruz J; Spencer S; Campbell AP; Sinner M; Reid H; Garten R; Katz JM; Fry AM; Barnes J; Wentworth DE
Euro Surveill; 2019 Jan; 24(3):. PubMed ID: 30670144
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses.
Kuroda T; Fukao K; Yoshida S; Oka R; Baba K; Ando Y; Taniguchi K; Noshi T; Shishido T
Viruses; 2023 May; 15(5):. PubMed ID: 37243240
[TBL] [Abstract][Full Text] [Related]
10. Influenza A virus polymerase acidic protein E23R substitution is a marker of reduced susceptibility to baloxavir.
Jones JC; Rovito SW; Penaflor MK; Webby RJ; Govorkova EA
Antiviral Res; 2022 Aug; 204():105369. PubMed ID: 35738347
[TBL] [Abstract][Full Text] [Related]
11. PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a cap-dependent endonuclease inhibitor.
Luo D; Ye Q; Li RT; Zhou HY; Guo JJ; Zhao SQ; Zhang S; Jiang T; Deng YQ; Qin CF
Virol Sin; 2023 Aug; 38(4):559-567. PubMed ID: 37290559
[TBL] [Abstract][Full Text] [Related]
12. Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility.
Jones JC; Pascua PNQ; Fabrizio TP; Marathe BM; Seiler P; Barman S; Webby RJ; Webster RG; Govorkova EA
Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8593-8601. PubMed ID: 32217734
[TBL] [Abstract][Full Text] [Related]
13. Baloxavir heralds a new era in influenza virus biology.
Kikuchi T; Watanabe A
Respir Investig; 2019 Jan; 57(1):1-2. PubMed ID: 30396860
[TBL] [Abstract][Full Text] [Related]
14. Mutated influenza A virus exhibiting reduced susceptibility to baloxavir marboxil from an experimentally infected horse.
Nemoto M; Tamura N; Bannai H; Tsujimura K; Kokado H; Ohta M; Yamanaka T
J Gen Virol; 2019 Nov; 100(11):1471-1477. PubMed ID: 31526451
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
Harada N; Shibata W; Koh H; Takashita E; Fujisaki S; Okamura H; Nanno S; Yamada K; Nakamae H; Hino M; Kakeya H
BMC Infect Dis; 2020 Jul; 20(1):478. PubMed ID: 32631240
[TBL] [Abstract][Full Text] [Related]
16. Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmission.
Jones JC; Zagribelnyy B; Pascua PNQ; Bezrukov DS; Barman S; Okda F; Webby RJ; Ivanenkov YA; Govorkova EA
PLoS Pathog; 2022 Jul; 18(7):e1010698. PubMed ID: 35830486
[TBL] [Abstract][Full Text] [Related]
17. Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
Hickerson BT; Petrovskaya SN; Dickensheets H; Donnelly RP; Ince WL; Ilyushina NA
J Virol; 2023 Jul; 97(7):e0015423. PubMed ID: 37404185
[TBL] [Abstract][Full Text] [Related]
18. Replicative Fitness of Seasonal Influenza A Viruses With Decreased Susceptibility to Baloxavir.
Chesnokov A; Patel MC; Mishin VP; De La Cruz JA; Lollis L; Nguyen HT; Dugan V; Wentworth DE; Gubareva LV
J Infect Dis; 2020 Jan; 221(3):367-371. PubMed ID: 31541547
[TBL] [Abstract][Full Text] [Related]
19. Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018.
Koszalka P; Tilmanis D; Roe M; Vijaykrishna D; Hurt AC
Antiviral Res; 2019 Apr; 164():91-96. PubMed ID: 30771405
[TBL] [Abstract][Full Text] [Related]
20. The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir.
Taniguchi K; Noshi T; Omoto S; Sato A; Shishido T; Matsuno K; Okamatsu M; Krauss S; Webby RJ; Sakoda Y; Kida H
Arch Virol; 2024 Jan; 169(2):29. PubMed ID: 38216710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
